Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.

A diminutive protein prompts a closer look at DNA dark matter.

The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.